Volska Kristine: Difference between revisions
From Bioblast
(Redirected page to Volska K) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{EAGLE | |||
|COST= Member | |||
|COST WG1=WG1 | |||
}} | |||
{{Person | |||
|lastname=Volska | |||
|firstname=Kristine | |||
|institution=[[File:Volska K.JPG|300px|right|Kristina Volska]] Laboratory of Pharmaceutical Pharmacology, | |||
Latvian Institute of Organic Synthesis, LV | |||
|address=Aizkraukles Street 21 | |||
|area code=LV-1006 | |||
|city=Riga | |||
|country=Latvia | |||
|Institution= | |||
|Area_Code= | |||
|City= | |||
|State_/_Province= | |||
|Country_name= | |||
|Weblink= | |||
|Field_of_research= | |||
|Topics= | |||
}} | |||
{{Labelingperson | |||
|field of research=Basic | |||
|Institution= | |||
|Area_Code= | |||
|City= | |||
|State_/_Province= | |||
|Country_name= | |||
|Weblink= | |||
|Field_of_research= | |||
|Topics= | |||
}} | |||
== Participated at == | |||
::::*[[MiP2018/MitoEAGLE Jurmala LV|MitoEAGLE 2018 Jurmala LV]] | |||
::::* [[IOC109| IOC109 Schroecken AT]] | |||
::::* [[IOC105| IOC105 Riga LV]] | |||
::::* [[MiPNet18.08_MiP2013|MiP2013 Obergurgl AT]] | |||
== Visiting scientist in the Oroboros O2k-Laboratory == | |||
:::: [[Image:O2k-Network.png|left|40px|link=O2k-Network|O2k-Network]] | |||
[[ Volska Kristine| Kristine Volska]]: Visiting scientist at the [[Oroboros Laboratories: visiting scientists |Oroboros O2k-Laboratory]] | |||
::::::* March 01 to April 01 2016 | |||
Latest revision as of 13:52, 17 March 2020
 |
News and Events |  |
 |
Working Groups | Short-Term Scientific Missions | Management Committee | Members |  |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Volska Kristine
MitoPedia topics: EAGLE
| Name | Volska Kristine, |
|---|---|
| Institution |  Latvian Institute of Organic Synthesis, LV |
| Address | Aizkraukles Street 21, LV-1006 |
| City | Riga |
| State/Province | |
| Country | Latvia |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | LV Riga Liepins E |
Labels:
Field of research: Basic
Publications
| Published | Reference | |
|---|---|---|
| BEC 2020.1 doi10.26124bec2020-0001.v1 | 2020 | Gnaiger E et al ― MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1 |
| Makrecka-Kuka 2017 Toxicol Lett | 2017 | Makrecka-Kuka M, Volska K, Antone U, Vilskersts R, Grinberga S, Bandere D, Liepinsh E, Dambrova M (2017) Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Toxicol Lett 267:32-8. |
| Makrecka-Kuka 2017 Sci Rep | 2017 | Makrecka-Kuka M, Sevostjanovs E, Vilks K, Volska K, Antone U, Kuka J, Makarova E, Pugovics O, Dambrova M, Liepinsh E (2017) Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues. Sci Rep 7:17528. |
| Liepinsh 2016 Biochem J | 2016 | Liepinsh E, Makrecka-Kuka M, Volska K, Kuka J, Makarova E, Antone U, Sevostjanovs E, Vilskersts R, Strods A, Tars K, Dambrova M (2016) Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria. Biochem J 473:1191-202. |
Abstracts
| Published | Reference | |
|---|---|---|
| Volska 2018 MiP2018 | 2018 | |
| Makrecka-Kuka 2016 Abstract MitoFit Science Camp 2016 | 2016 | Long-chain acylCoAs vs acylcarnitines in mitochondrial bioenergetics: from in vitro to in vivo. |
| Makrecka 2013 Abstract MiP2013 | 2013 | Makrecka-Kuka M, Volska K, Kuka J, Liepins E, Dambrova M (2013) The accumulation of long chain acyl-carnitines is a major cause of mitochondrial damage during ischemia. Mitochondr Physiol Network 18.08. |
| Volska 2013 Abstract MiP2013 | 2013 | Volska K, Makrecka-Kuka M, Svalbe B, Dambrova M (2013) The inhibitor of L-carnitine biosynthesis protects brain mitochondria against anoxia-reoxygenation injury. Mitochondr Physiol Network 18.08. |
Participated at
Visiting scientist in the Oroboros O2k-Laboratory
Kristine Volska: Visiting scientist at the Oroboros O2k-Laboratory
- March 01 to April 01 2016
